Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28383226 | 1.00 | PTPN1 (0.51) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL1304541 | 1.00 | PTPN1 (0.51) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL11381092 | 0.93 | PTPN1 (0.63) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL1305488 | 0.93 | KDM1A (0.56) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL1305486 | 0.93 | KDM1A (0.56) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL11381093 | 0.93 | PTPN1 (0.63) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL11564583 | 0.82 | PTPN1 (0.46) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL11564586 | 0.82 | PTPN1 (0.46) | PTPN1KDM1APTGS1PDE4ASNCA | |
| SCHEMBL31659073 | 0.79 | TSHR (0.31) | PTPN1 | |
| SCHEMBL31659101 | 0.79 | TSHR (0.31) | PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7012120-B2 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | HENKEL CORPORATION (US) | 2006-03-14 | — | — | US | claimed |
| US-20050288458-A1 | Reworkable thermosetting resin composition | KLEMARCZYK PHILIP T | 2005-12-29 | — | — | US | claimed |
| US-20030073770-A1 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | Henkel IP & Holding GmbH (DE) | 2003-04-17 | — | — | US | claimed |
| US-8053587-B2 | for mounting onto a circuit board semiconductor devices | HENKEL CORPORATION (US) | 2011-11-08 | — | — | US | disclosed |
| US-20080214840-A1 | Reworkable thermosetting resin composition | HENKEL CORPORATION (US) | 2008-09-04 | — | — | US | disclosed |
| US-7012120-B2 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | HENKEL CORPORATION (US) | 2006-03-14 | — | — | US | disclosed |
| US-20050288458-A1 | Reworkable thermosetting resin composition | KLEMARCZYK PHILIP T | 2005-12-29 | — | — | US | disclosed |
| US-20030073770-A1 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | Henkel IP & Holding GmbH (DE) | 2003-04-17 | — | — | US | disclosed |
| US-4293497-A | ALKYLATION CATALYSTS, VIATMIN E | SCM CORPORATION (US) | 1981-10-06 | — | — | US | disclosed |
| US-4292454-A | INTERMEDIATES FOR VITAMIN E | SCM CORPORATION (US) | 1981-09-29 | — | — | US | disclosed |
| US-4292459-A | Coupling reaction involving a Grignard and allylic halide | SCM CORPORATION (US) | 1981-09-29 | — | — | US | disclosed |
| US-4228313-A | TO PREPARE A REARRANGED UNSATURATED HYDROCARBON | SCM CORPORATION (US) | 1980-10-14 | — | — | US | disclosed |
| US-4221742-A | Coupling reaction involving a Grignard and allylic halide | SCM CORPORATION (US) | 1980-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214840-A1 | Reworkable thermosetting resin composition | GSS, LSS, LRBA | PTPN1 1073/4885KDM1A 226/4885PTGS1 2299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.